Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endothelial Cell Signaling and Microcirculatory Flow in Severe Sepsis

NCT00793442 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.

NCT NCT00793442
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00793442 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endothelial Cell Signaling and Microcirculatory Flow in Severe Sepsis
Lead sponsor
Beth Israel Deaconess Medical Center
Phase
Observational
Overall status
Completed
Start date
March 31, 2008
Completion date
May 31, 2013
Enrollment
910 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis, septic shock, severe sepsis